Subcutaneous Injection
Links shared publicly online about this topic
Subcutaneous Injection Videos - Learn How To Inject
hopkins-arthritis.org — “Subcutaneous Injections with TNFa Inhibitors: A video discussion from the Johns Hopkins Arthritis Center” View full resource at hopkins-arthritis.org
Most Recently Shared on August 28, 2009 at 8:48 pm By:
Johns Hopkins Arthritis Center Videos:Learn how to inject your Arthritis Medication - http://bit.ly/rY9gY
How to give a subcutaneous injection by Johns Hopkins Arthritis
hopkins-arthritis.org — “Giving a subcutaneous injection - Johns Hopkins Medicine.” View full resource at hopkins-arthritis.org
Most Recently Shared on March 27, 2009 at 6:30 pm By:
Johns Hopkins Arthritis Alerts: Do you know how to give yourself a subcutaneous injection? Read how here! http://ow.ly/1xDC
How to Give a Subcutaneous Injection -- Articles -- FertilityAuthority.com
fertilityauthority.com — “Basic instructions for you or your partner Some fertility drugs are injected subcutaneously, with a very small needle, just under the skin --" usually in the thigh, stomach or back of the arm. The medication may come in a prefilled syringe, as a” View full resource at fertilityauthority.com
Most Recently Shared on August 30, 2010 at 1:11 pm By:
FertilityAuthority Health Site
How to Give a Subcutaneous Injection http://bit.ly/d6cT09 #fertility
Chemo Therapy - Oral, Subcutaneous Injection, Picc Line - Hickman, Groshong Catheter
chemocare.com — “Chemo therapy drugs can be given in a variety of different ways. The method of administration along with the dose is determined by rigorous testing called clinical trials, which are done prior to the drug being available for commercial use with patients. Chemo Therapy - Oral, Subcutaneous Injection, Picc Line - Hickman, Groshong Catheter” View full resource at chemocare.com
Most Recently Shared on August 26, 2009 at 1:28 pm By:
How chemotherapy is given: what's a PICC line, a tunneled cath, a port, etc.? http://bit.ly/dgzZy
Efficacy of Sublingual Immunotherapy versus Subcutaneous Injection Immunotherapy in Allergic Patients
hindawi.com — “While it is generally accepted that Subcutaneous Injection Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT) are both efficacious, there is not yet a significant amount of information regarding their comparative efficacy. In this paper, we performed a retrospective chart review and compared treatment results in two groups of patients (both with nasal allergies with or without asthma) that were treated either with SCIT or SLIT. Both treatment modalities were found to be of similar efficacy” View full resource at hindawi.com
Most Recently Shared on April 25, 2012 at 12:17 am By:
John Weiner Allergist, Physician, Doctor, and Internist
Full text US observational series of SCIT v SLIT in allergy. Useful data http://t.co/immH2CZJ
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemnt Compared To Intraveous Therapy
medicalnewstoday.com — “(NYSE:BMY) announced that new Phase III clinical data show that a weekly subcutaneous injection of an investigational formulation of ORENCIA® (abatacept), following a single intravenous (I.V.)” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 5:05 pm By:
MNT Arthritis News Health News
New Data Show That Subcutaneous Injection Of An Investigational Formulation Of ORENCIA® Provided Similar Improvemn... http://mnt.to/3Mm7
Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC
news-medical.net — “Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).” View full resource at news-medical.net
Most Recently Shared on September 22, 2010 at 2:05 pm By:
Irritable Bowel Syndrome OW Health
Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC: Progenics ... http://bit.ly/bqhznN
Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC
news-medical.net — “Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).” View full resource at news-medical.net
Most Recently Shared on September 22, 2010 at 10:35 am By:
Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC: Progenics ... http://bit.ly/ci10LJ
Allergy Notes: Icatibant subcutaneous injection (Firazyr) can be self-administered by patients upon recognition of HAE attack
allergynotes.blogspot.com — “Allergy and Asthma News Updated Daily by Allergist and Assistant Professor at University of Chicago” View full resource at allergynotes.blogspot.com
Most Recently Shared on August 26, 2011 at 1:05 pm By:
allergydropz Surgeon, ENT Doctor, Physician, and Doctor
Allergy Notes: Icatibant subcutaneous injection (Firazyr) can be self-administered by: http://t.co/UwNOJBN Full http://t.co/Bv1xv8x
Abatacept has received FDA approval as a Subcutaneous Injection for Rheumatoid Arthritis http://ow.ly/5TWbD
medpagetoday.com — “Abatacept has received FDA approval as a Subcutaneous Injection for Rheumatoid Arthritis http://ow.ly/5TWbD” View full resource at medpagetoday.com
Most Recently Shared on August 3, 2011 at 10:45 am By:
Dr Irwin Lim Rheumatologist, Physician, Active Health Library, and Doctor
Abatacept has received FDA approval as a Subcutaneous Injection for Rheumatoid Arthritis http://ow.ly/5TWbD
Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy - Schuller-Petrović - 2010 - Journal of the European Academy of Dermatology and Venereology -
onlinelibrary.wiley.com — “Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy - Schuller-Petrović - 2010 - Journal of the European Academy of Dermatology and Venereology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on October 16, 2010 at 9:58 am By:
Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during... http://bit.ly/9DiCN2
Rheumatology Medical News about Injections, Subcutaneous Sodium Salicylate Osteoarthritis Thumb
mdlinx.com — “A randomised controlled trial of subcutaneous sodium salicylate therapy for osteoarthritis of the thumb” View full resource at mdlinx.com
Most Recently Shared on June 23, 2010 at 5:09 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A randomised controlled trial of subcutaneous sodium salicylate therapy for osteoarthritis of the thu... http://bit.ly/9vpxBL #Rheumatology
Allergy/Immunology News & Articles - MDLinx - Asthma Injections, Subcutaneous; omalizumab on #MDlinx
mdlinx.com — “Allergy/Immunology News & Articles - MDLinx - Asthma Injections, Subcutaneous; omalizumab on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on August 10, 2010 at 11:03 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and safety of subcutaneous omalizumab versus placebo as add on therapy to corticosteroids for ... http://bit.ly/cnb6bx #AI #mdlinx
Family Med Medical News about Injections, Subcutaneous Sodium Salicylate Osteoarthritis Thumb
mdlinx.com — “A randomised controlled trial of subcutaneous sodium salicylate therapy for osteoarthritis of the thumb” View full resource at mdlinx.com
Most Recently Shared on June 22, 2010 at 9:25 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A randomised controlled trial of subcutaneous sodium salicylate therapy for osteoarthritis of the thumb... http://bit.ly/bwtFuM #GM #mdlinx
Fast-updosed subcutaneous immunotherapy effective
medicalxpress.com — “(HealthDay) -- An immunologically-enhanced subcutaneous immunotherapy (SCIT) formulation, with an optimized ratio of allergen to adjuvant, induces a significant immunologic response with acceptable safety when injected every three to four days compared with standard weekly injections, according to a ...” View full resource at medicalxpress.com
Most Recently Shared on March 16, 2012 at 9:47 am By:
PhysOrg Health News Health News
Fast-updosed subcutaneous immunotherapy effective http://t.co/VFd6GDJw
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
JH Arthritis Center
News and Information from the Johns Hopkins Arthritis Center
-
JH Arthritis Center
News and Information from the Johns Hopkins Arthritis Center
-
FertilityAuthority
Your most trusted source for everything fertility.
Advertisement
